Comparing the rectal Indomethacin plus Mesna versus rectal indomethacin on prevention of post Endoscopic Retrograde Cholangio-pnacreatography pancreatitis

Phase 3

Recruiting

• Conditions: Other acute pancreatitis; Pancreatitis.; K85.8

• Registration Number: IRCT20121021011192N16
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 698

Inclusion Criteria

Patients undergoing ERCP in Taleghani hospital by taking written consent

Exclusion Criteria

Patients history of hypersensitivity against each of indomethacin or mesna
Patients history of sphinctrotomy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pancreatitis. Timepoint: 10 days after doing Endoscopic Retrograde Cholangio-pancreatography. Method of measurement: Clinical evaluation.

Secondary Outcome Measures

Name	Time	Method
Gastrointestinal bleeding. Timepoint: 10 days after doing Endoscopic Retrograde Cholangio-pancreatography. Method of measurement: Clinical evaluation.